XML 50 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Business segment information (Tables)
12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Schedule of Net Sales by SBU Reporting Segment

The table below presents net sales by SBU reporting segment. Net sales include product sales and marketing service fees.

 

 

 

Year Ended December 31,

 

(U.S. Dollars in thousands)

 

2015

 

 

2014

 

 

2013

 

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

BioStim

 

$

164,955

 

 

 

41.6

%

 

$

154,676

 

 

 

38.5

%

 

$

145,085

 

 

 

36.5

%

Biologics

 

 

59,832

 

 

 

15.1

%

 

 

55,881

 

 

 

13.9

%

 

 

53,746

 

 

 

13.5

%

Extremity Fixation

 

 

96,034

 

 

 

24.2

%

 

 

109,678

 

 

 

27.3

%

 

 

103,359

 

 

 

26.0

%

Spine Fixation

 

 

75,668

 

 

 

19.1

%

 

 

82,042

 

 

 

20.4

%

 

 

95,421

 

 

 

24.0

%

Total net sales

 

$

396,489

 

 

 

100.0

%

 

$

402,277

 

 

 

100.0

%

 

$

397,611

 

 

 

100.0

%

 

Summary of Net Margin, Defined as Gross Profit Less Sales and Marketing Expenses from Continuing Operations by SBU Reporting Segment

The table below presents net margin, defined as gross profit less sales and marketing expenses by SBU reporting segment:

 

Net Margin by SBU

 

Year Ended December 31,

 

(U.S. Dollars in thousands)

 

2015

 

 

2014

 

 

2013

 

Net margin

 

 

 

 

 

 

 

 

 

 

 

 

BioStim

 

$

67,878

 

 

$

66,096

 

 

$

63,847

 

Biologics

 

 

27,226

 

 

 

26,629

 

 

 

24,794

 

Extremity Fixation

 

 

29,493

 

 

 

31,586

 

 

 

23,704

 

Spine Fixation

 

 

8,547

 

 

 

14,243

 

 

 

4,329

 

Corporate

 

 

(1,260

)

 

 

(1,736

)

 

 

(1,443

)

Total net margin

 

$

131,884

 

 

$

136,818

 

 

$

115,231

 

General and administrative

 

 

87,157

 

 

 

79,074

 

 

 

67,517

 

Research and development

 

 

26,389

 

 

 

24,994

 

 

 

26,768

 

Restatements and related costs

 

 

9,083

 

 

 

15,614

 

 

 

12,945

 

Impairment of goodwill

 

 

 

 

 

 

 

 

19,193

 

Operating income (loss)

 

$

9,255

 

 

$

17,136

 

 

$

(11,192

)

 

Schedule of Depreciation and Amortization by GBU Reporting Segment

The following table presents depreciation and amortization by SBU reporting segment:

 

 

 

Year Ended December 31,

 

(U.S. Dollars in thousands)

 

2015

 

 

2014

 

 

2013

 

BioStim

 

$

2,933

 

 

$

1,623

 

 

$

1,979

 

Biologics

 

 

1,157

 

 

 

1,161

 

 

 

648

 

Extremity Fixation

 

 

6,636

 

 

 

8,442

 

 

 

7,265

 

Spine Fixation

 

 

10,050

 

 

 

11,711

 

 

 

12,834

 

Corporate

 

 

147

 

 

 

(59

)

 

 

96

 

Total

 

$

20,923

 

 

$

22,878

 

 

$

22,822

 

 

Summary of Net Sales by Geographic Destination

The following data includes net sales by geographic destination:

 

(U.S. Dollars in thousands)

 

2015

 

 

2014

 

 

2013

 

U.S.

 

$

305,505

 

 

$

294,682

 

 

$

293,032

 

Italy

 

 

15,655

 

 

 

19,573

 

 

 

16,755

 

United Kingdom

 

 

11,376

 

 

 

11,402

 

 

 

10,002

 

Brazil

 

 

13,512

 

 

 

19,633

 

 

 

26,786

 

Others

 

 

50,441

 

 

 

56,987

 

 

 

51,036

 

Total net sales

 

$

396,489

 

 

$

402,277

 

 

$

397,611

 

 

Summary of Property, Plant and Equipment of Reporting Segments by Geographic Area

The following data includes property, plant and equipment by geographic area:

 

(U.S. Dollars in thousands)

 

2015

 

 

2014

 

U.S.

 

$

42,534

 

 

$

37,029

 

Italy

 

 

6,015

 

 

 

6,865

 

United Kingdom

 

 

998

 

 

 

1,368

 

Brazil

 

 

1,036

 

 

 

1,308

 

Others

 

 

1,723

 

 

 

1,979

 

Total

 

$

52,306

 

 

$

48,549